JP2018196385A5 - - Google Patents

Download PDF

Info

Publication number
JP2018196385A5
JP2018196385A5 JP2018145578A JP2018145578A JP2018196385A5 JP 2018196385 A5 JP2018196385 A5 JP 2018196385A5 JP 2018145578 A JP2018145578 A JP 2018145578A JP 2018145578 A JP2018145578 A JP 2018145578A JP 2018196385 A5 JP2018196385 A5 JP 2018196385A5
Authority
JP
Japan
Prior art keywords
birc5
normalized
ube2c
breast cancer
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018145578A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018196385A (ja
JP7042717B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018196385A publication Critical patent/JP2018196385A/ja
Publication of JP2018196385A5 publication Critical patent/JP2018196385A5/ja
Application granted granted Critical
Publication of JP7042717B2 publication Critical patent/JP7042717B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018145578A 2009-11-23 2018-08-02 癌の臨床転帰を予測する方法 Active JP7042717B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26376309P 2009-11-23 2009-11-23
US61/263,763 2009-11-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016129697A Division JP2016214245A (ja) 2009-11-23 2016-06-30 癌の臨床転帰を予測する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020218527A Division JP2021058207A (ja) 2009-11-23 2020-12-28 癌の臨床転帰を予測する方法

Publications (3)

Publication Number Publication Date
JP2018196385A JP2018196385A (ja) 2018-12-13
JP2018196385A5 true JP2018196385A5 (show.php) 2019-02-28
JP7042717B2 JP7042717B2 (ja) 2022-03-28

Family

ID=44060376

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2012540103A Active JP5964752B2 (ja) 2009-11-23 2010-11-19 癌の臨床転帰を予測する方法
JP2016129697A Pending JP2016214245A (ja) 2009-11-23 2016-06-30 癌の臨床転帰を予測する方法
JP2018145578A Active JP7042717B2 (ja) 2009-11-23 2018-08-02 癌の臨床転帰を予測する方法
JP2020218527A Pending JP2021058207A (ja) 2009-11-23 2020-12-28 癌の臨床転帰を予測する方法
JP2022123265A Pending JP2022166064A (ja) 2009-11-23 2022-08-02 癌の臨床転帰を予測する方法
JP2022129605A Pending JP2022169647A (ja) 2009-11-23 2022-08-16 癌の臨床転帰を予測する方法
JP2023213416A Pending JP2024037948A (ja) 2009-11-23 2023-12-18 癌の臨床転帰を予測する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012540103A Active JP5964752B2 (ja) 2009-11-23 2010-11-19 癌の臨床転帰を予測する方法
JP2016129697A Pending JP2016214245A (ja) 2009-11-23 2016-06-30 癌の臨床転帰を予測する方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2020218527A Pending JP2021058207A (ja) 2009-11-23 2020-12-28 癌の臨床転帰を予測する方法
JP2022123265A Pending JP2022166064A (ja) 2009-11-23 2022-08-02 癌の臨床転帰を予測する方法
JP2022129605A Pending JP2022169647A (ja) 2009-11-23 2022-08-16 癌の臨床転帰を予測する方法
JP2023213416A Pending JP2024037948A (ja) 2009-11-23 2023-12-18 癌の臨床転帰を予測する方法

Country Status (13)

Country Link
US (4) US20110123990A1 (show.php)
EP (4) EP3739060A1 (show.php)
JP (7) JP5964752B2 (show.php)
AU (1) AU2010321829B2 (show.php)
CA (2) CA2776751C (show.php)
DK (1) DK2504451T3 (show.php)
ES (1) ES2735993T3 (show.php)
HU (1) HUE044374T2 (show.php)
IL (5) IL219051A (show.php)
MX (3) MX337650B (show.php)
NZ (1) NZ599194A (show.php)
PL (1) PL2504451T3 (show.php)
WO (1) WO2011063274A2 (show.php)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
ES2636470T3 (es) 2004-04-09 2017-10-05 Genomic Health, Inc. Marcadores de expresión génica para predecir la respuesta a la quimioterapia
CA2585571C (en) * 2004-11-05 2020-01-21 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
WO2007123772A2 (en) 2006-03-31 2007-11-01 Genomic Health, Inc. Genes involved in estrogen metabolism
NZ590385A (en) * 2008-06-26 2012-11-30 Dana Farber Cancer Inst Inc Signatures and determinants associated with metastasis and methods of use thereof
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
DK177532B1 (en) 2009-09-17 2013-09-08 Bio Bedst Aps Medical use of sPLA2 hydrolysable liposomes
NZ599194A (en) * 2009-11-23 2014-07-25 Genomic Health Inc Methods to predict clinical outcome of cancer
EP3831964B1 (en) 2010-01-11 2025-04-16 Genomic Health, Inc. Method to use gene expression to determine likelihood of clinical outcome of renal cancer
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
EP3812469A1 (en) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
MX359416B (es) 2010-07-27 2018-09-27 Genomic Health Inc Metodo para emplear expresion genica para determinar pronostico de cancer de prostata.
WO2012030840A2 (en) 2010-08-30 2012-03-08 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
CA2831074A1 (en) * 2011-03-26 2012-10-04 Oregon Health And Science University Gene expression predictors of cancer prognosis
CA2840472A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of bladder cancer
WO2013006495A2 (en) * 2011-07-01 2013-01-10 Dana-Farber Cancer Institute, Inc. Methods of predicting prognosis in cancer
KR102003660B1 (ko) * 2011-07-13 2019-07-24 더 멀티플 마이얼로머 리서치 파운데이션, 인크. 데이터 수집 및 분배 방법
JP2014525240A (ja) * 2011-08-16 2014-09-29 オンコサイト コーポレーション 乳癌の治療および診断のための方法および組成物
WO2013070521A1 (en) * 2011-11-08 2013-05-16 Genomic Health, Inc. Method of predicting breast cancer prognosis
JP5805518B2 (ja) * 2011-12-21 2015-11-04 株式会社島津製作所 マルチプレックス大腸がんマーカーパネル
EP2809812A4 (en) 2012-01-31 2016-01-27 Genomic Health Inc GENE EXPRESSION PROFILE ALGORITHM AND PROSTATE CANCER PROGNOSTIC DETERMINATION TEST
GB201206323D0 (en) * 2012-04-10 2012-05-23 Immunovia Ab Methods and arrays for use in the same
US20150184247A1 (en) * 2012-04-20 2015-07-02 Memorial Sloan-Kettering Cancer Center Gene expression profiles associated with metastatic breast cancer
US20150299799A1 (en) 2012-10-05 2015-10-22 Michael Sturzl Method for Detecting an Increased Risk or Incidence of Colorectal Cancer
WO2014078700A1 (en) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Gene signatures for cancer prognosis
KR101672531B1 (ko) * 2013-04-18 2016-11-17 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
AU2014274135B2 (en) * 2013-05-30 2020-04-09 Genomic Health, Inc. Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
WO2014195032A1 (en) * 2013-06-07 2014-12-11 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
WO2015138769A1 (en) * 2014-03-12 2015-09-17 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for assessing patients with non-small cell lung cancer
CA2947624A1 (en) * 2014-05-13 2015-11-19 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US10570457B2 (en) 2014-09-26 2020-02-25 Medical Prognosis Institute A/S Methods for predicting drug responsiveness
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
WO2016092299A1 (en) * 2014-12-09 2016-06-16 Medical Research Council Methods and kits for predicting the response to therapy of cancer
CN107532124B (zh) 2015-03-27 2022-08-09 精密科学公司 检测食管疾病
WO2017075061A1 (en) 2015-10-30 2017-05-04 Exact Sciences Corporation Multiplex amplification detection assay and isolation and detection of dna from plasma
AU2016369603A1 (en) 2015-12-18 2018-07-05 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers
SG11201901466PA (en) * 2016-09-07 2019-03-28 Agency Science Tech & Res A method of identifying risk of cancer and therapeutic options
US9725769B1 (en) 2016-10-07 2017-08-08 Oncology Venture ApS Methods for predicting drug responsiveness in cancer patients
AU2017258901A1 (en) 2016-12-30 2018-07-19 Allarity Therapeutics Europe ApS Methods for predicting drug responsiveness in cancer patients
AU2018211956B2 (en) 2017-01-27 2024-06-20 Exact Sciences Corporation Detection of colon neoplasia by analysis of methylated DNA
WO2018212192A1 (ja) * 2017-05-18 2018-11-22 京都府公立大学法人 癌の予後及び／又は転移可能性を評価する方法及びマーカー
US12275994B2 (en) * 2017-06-22 2025-04-15 Clear Gene, Inc. Methods and compositions for the analysis of cancer biomarkers
CN110268383A (zh) 2017-11-13 2019-09-20 多发性骨髓瘤研究基金会公司 综合、分子、组学、免疫疗法、代谢、表观遗传学和临床数据库
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
US11549152B2 (en) * 2018-03-08 2023-01-10 University Of Notre Dame Du Lac Products for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon
JP7199045B2 (ja) * 2018-04-13 2023-01-05 国立大学法人大阪大学 乳癌の予後に関する情報の取得方法、乳癌の予後の判定装置及びコンピュータプログラム
WO2020059850A1 (ja) * 2018-09-21 2020-03-26 国立大学法人東京大学 がんの予後判定方法
JP2019032334A (ja) * 2018-10-03 2019-02-28 イムノヴィア・アクチエボラーグ 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ
KR102216645B1 (ko) * 2018-10-29 2021-02-17 사회복지법인 삼성생명공익재단 폐암의 분자 아형 결정을 위한 바이오마커 패널 및 이의 용도
AU2019392939A1 (en) * 2018-12-08 2021-06-24 Decipher Biosciences, Inc. Transcriptomic profiling for prognosis of breast cancer
EP3964590B1 (en) * 2019-05-03 2026-02-18 DCGEN Co., Ltd. Method of predicting cancer prognosis and composition for same
CN111235270B (zh) * 2019-08-29 2022-04-29 北京臻知医学科技有限责任公司 一种基于高通量测序法的肿瘤抗原表达检测引物及试剂盒
US12165747B2 (en) * 2020-01-23 2024-12-10 The Broad Institute, Inc. Molecular spatial mapping of metastatic tumor microenvironment
EP4291676A4 (en) * 2021-02-12 2025-05-07 Mammogen, Inc. Biomarkers for the diagnosis of breast cancer
WO2022192128A2 (en) * 2021-03-08 2022-09-15 Castle Biosciences, Inc. Determining prognosis and treatment based on clinical-pathologic factors and continuous multigene-expression profile scores
CN117116345B (zh) * 2023-07-24 2025-09-16 中国人民解放军军事科学院军事医学研究院 一种基于基因调控网络构建患者生存网络的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
JP2005500832A (ja) * 2001-06-18 2005-01-13 ロゼッタ・インファーマティクス・インコーポレーテッド 乳癌患者の診断および予後
AU2002322280A1 (en) * 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DK1918386T3 (da) * 2002-03-13 2012-01-02 Genomic Health Inc Genekspressionsprofiler i biopsier af tumorvæv
US20040067234A1 (en) * 2002-07-11 2004-04-08 Paz Einat Isocitrate dehydrogenase and uses thereof
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
ES2905579T3 (es) * 2003-07-10 2022-04-11 Genomic Health Inc Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
CA2558808A1 (en) * 2004-03-05 2005-09-22 Rosetta Inpharmatics Llc Classification of breast cancer patients using a combination of clinical criteria and informative genesets
CA2582739A1 (en) * 2004-09-30 2006-04-13 Bayer Healthcare Ag Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy
KR20080004551A (ko) * 2005-04-01 2008-01-09 엔씨씨 테크놀로지 벤쳐스 피티이 리미티드 유방암 분류에 관한 재료 및 방법
WO2006133460A2 (en) * 2005-06-09 2006-12-14 Yale University Methods for diagnosing and treating breast cancer based on a her/er ratio
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2006138275A2 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
TWI304443B (en) * 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
WO2007123772A2 (en) * 2006-03-31 2007-11-01 Genomic Health, Inc. Genes involved in estrogen metabolism
AU2008264893A1 (en) * 2007-04-16 2008-12-24 Inserm- Institut National De La Sante Et De La Recherche Medicale Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
WO2009095319A1 (en) * 2008-01-28 2009-08-06 Siemens Healthcare Diagnostics Gmbh Cancer prognosis by majority voting
WO2009132928A2 (en) * 2008-05-02 2009-11-05 Siemens Healthcare Diagnostics Gmbh Molecular markers for cancer prognosis
EP2294215B1 (en) * 2008-05-12 2013-01-16 Genomic Health, Inc. Tests to predict responsiveness of cancer patients to chemotherapy treatment options
NZ599194A (en) * 2009-11-23 2014-07-25 Genomic Health Inc Methods to predict clinical outcome of cancer

Similar Documents

Publication Publication Date Title
JP2018196385A5 (show.php)
JP2016214245A5 (show.php)
Huang et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
Smirnov et al. Global gene expression profiling of circulating tumor cells
JP2021177761A5 (show.php)
JP2020188787A (ja) 膵臓がんの検出キット又はデバイス及び検出方法
JP2010538609A5 (show.php)
JP2016174600A5 (show.php)
CN106148529B (zh) 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用
Marín-Aguilera et al. Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
JP2016521979A5 (show.php)
Wan et al. Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer
JP6611411B2 (ja) 膵臓がんの検出キット及び検出方法
Zhao et al. Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma
Zhu et al. Long intergenic non-protein coding RNA 1006 used as a potential novel biomarker of gastric cancer
CN109477147A (zh) 用于皮肤癌分期和治疗的方法和材料
AU2017282420A1 (en) MMP1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method
WO2020032228A1 (ja) 前立腺がんの検出のためのキット、デバイス及び方法
Lin et al. Down-regulation of tissue microRNA-126 was associated with poor prognosis in patients with cutaneous melanoma
CN111172285A (zh) 用于胰腺癌早期诊断和/或预后监测的miRNA组及其应用
Jani et al. Examining trends in kidney cancer mortality by gender and race in the United States: A 20-year analysis
CN107858424B (zh) miRNA-4731-3p作为原发性肺癌诊断标志物的应用
WO2020135422A1 (zh) 健康风险评估方法
CN116479123A (zh) m7G相关lncRNA作为生物标志物在肝癌预后或治疗反应预测中的应用及产品和系统
Pycha et al. Evaluation of the M371-test under real-life conditions for diagnosis and follow up of testicular germ cell tumors